Archford Capital Strategies’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,764
| Closed | -$338K | – | 260 |
|
|
2024
Q1 | $338K | Buy |
11,764
+267
| +2% | +$7.68K | 0.06% | 209 |
|
|
2023
Q4 | $377K | Buy |
11,497
+3,407
| +42% | +$112K | 0.07% | 191 |
|
|
2023
Q3 | $225K | Sell |
8,090
-39
| -0.5% | -$1.09K | 0.05% | 252 |
|
|
2023
Q2 | $295K | Sell |
8,129
-220
| -3% | -$7.99K | 0.06% | 245 |
|
|
2023
Q1 | $243K | Buy |
8,349
+301
| +4% | +$8.76K | 0.05% | 251 |
|
|
2022
Q4 | $227K | Sell |
8,048
-921
| -10% | -$26K | 0.05% | 254 |
|
|
2022
Q3 | $295K | Buy |
8,969
+12
| +0.1% | +$395 | 0.08% | 228 |
|
|
2022
Q2 | $282K | Buy |
8,957
+261
| +3% | +$8.22K | 0.07% | 235 |
|
|
2022
Q1 | $403K | Buy |
8,696
+595
| +7% | +$27.6K | 0.09% | 206 |
|
|
2021
Q4 | $496K | Sell |
8,101
-2,440
| -23% | -$149K | 0.11% | 188 |
|
|
2021
Q3 | $788K | Buy |
10,541
+412
| +4% | +$30.8K | 0.19% | 138 |
|
|
2021
Q2 | $937K | Buy |
10,129
+14
| +0.1% | +$1.3K | 0.23% | 115 |
|
|
2021
Q1 | $914K | Buy |
10,115
+822
| +9% | +$74.3K | 0.24% | 110 |
|
|
2020
Q4 | $984K | Buy |
9,293
+1,763
| +23% | +$187K | 0.23% | 130 |
|
|
2020
Q3 | $480K | Buy |
7,530
+362
| +5% | +$23.1K | 0.13% | 176 |
|
|
2020
Q2 | $374K | Buy |
+7,168
| New | +$374K | 0.11% | 183 |
|